AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)

AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)

No trades
See on Supercharts
Market capitalization
‪15.59 M‬USD
−4.04USD
‪−17.05 M‬USD
‪107.40 M‬USD
‪5.36 M‬
Beta (1Y)
1.00

About AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)

CEO
Joshua R. Disbrow
Headquarters
Englewood
Employees (FY)
150
Founded
2002
FIGI
BBG0101PY0G6
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0A8M is 2.76 USD — it has decreased by 3.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stocks are traded under the ticker 0A8M.
AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
0A8M stock is 3.26% volatile and has beta coefficient of 1.00. Check out the list of the most volatile stocks — is AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) there?
0A8M earnings for the last quarter are −1.48 USD per share, whereas the estimation was −0.04 USD resulting in a ‪−3.60 K‬% surprise. The estimated earnings for the next quarter are −0.25 USD per share. See more details about AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) earnings.
AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) revenue for the last quarter amounts to ‪22.10 M‬ USD despite the estimated figure of ‪27.73 M‬ USD. In the next quarter revenue is expected to reach ‪21.75 M‬ USD.
Yes, you can track AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
0A8M stock has risen by 0.73% compared to the previous week, the month change is a 10.29% fall, over the last year AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) has showed a 2.60% increase.
0A8M net income for the last quarter is ‪−220.00 K‬ USD, while the quarter before that showed ‪−8.12 M‬ USD of net income which accounts for 97.29% change. Track more AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financial stats to get the full picture.
Today AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) has the market capitalization of ‪15.59 M‬, it has decreased by 1.76% over the last week.
No, 0A8M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0A8M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
0A8M reached its all-time high on Apr 26, 2021 with the price of 142.50 USD, and its all-time low was 1.40 USD and was reached on Jun 29, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 150.00 employees. See our rating of the largest employees — is AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock shows the sell signal. See more of AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) future price: according to them, 0A8M price has a max estimate of 8.00 USD and a min estimate of 8.00 USD. Read a more detailed AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) forecast: see what analysts think of AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) EBITDA is ‪3.32 M‬ USD, and current EBITDA margin is −3.27%. See more stats in AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financial statements.